Ellume, partner or not?, page-40

Good1234, The article says what it is to do ,it's looking like it works , the market for this device will be huge , from cruse ships , hospitals , local practices , the military to border control , multiple tests from 1 cartridge will disrupt the POC would be competition , Anteo is not a one trick pony but true the market will wake up when management put out announcements that gives the market more certainty , for now all investors can do is read between the lines.

The device will enable medical professionals to rapidly identify and treat life-threatening diseases through a diagnostic system that can detect and differentiate between multiple infectious disease agents within a single test cartridge at the point of care.
Industry partners Lumos Diagnostics (a wholly-owned subsidiary of medical technology firm Planet Innovation), Anteo Technologies and research partner Deakin University are collaborating on the project.